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Clinical Guidelines Written by Residents
David W. Andrews, MD
Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania

“Variation” is an innocent word that that can represent many levels of frustration to the clinician. Variation among patients is the least of these;
the physician expects patients and their individual problems to be as diverse as the human race itself. Variation within a practice should be due
to matching the specific needs of the specific patient. Other variations can mean trouble if they represent differences in understanding of the
problem among clinicians and other allied health practitioners. These differences could be between institutions or even between shifts within
one institution.
The Tufts Health Care Institute (THCI) is a non-profit organization which provides educational tools for medical and surgical residents across
the US. One of these tools teaches clinical practice guidelines, defined by the Institute of Medicine as “systematically developed statements to
assist practitioner and patient decisions about appropriate health care for specific clinical circumstances.”1. One of the authors of the Clinical
Guidelines module is David B. Nash, Professor of Health Policy here at Thomas Jefferson University.
The Jefferson Department of Neurological Surgery has been participating in the THCI program for the past few years, mentored by Dr. David W.
Andrews of the department. Because surgery and medicine have different emphases, Dr. Andrews has found that some of the THCI modules are
more appropriate than others for the neurosurgical residents, and that the Clinical Guidelines module in particular has generated both enthusiasm
and good results. A selection of the TJU neurosurgical resident-generated guidelines are presented here. These guidelines have not officially been
adopted by the department or by any institution that we know of, but show how clinical problems can be identified and solved.
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Anticonvulsant use in brain tumor patients
Hugh Moulding, MD

More than 200,000 patients are diagnosed with primary or metastatic brain tumors each year in
the United States. Of these patients, 20% to 40% will develop seizures at presentation, and another
20% to 40% will require treatment for seizures during their illness. Although the use of antiepileptic
drugs (AEDs) in patients who have had seizures seems reasonable, the issue of prophylactic AED
use for patients who have not had a seizure is an intensely debated subject.
At TJUH, we see the wide variety of practices in prophylactic use of anticonvulsants. Some physicians will use anticonvulsants and follow therapeutic levels, others will use a starting dose of AED
and not follow levels, and still others will not use AED at all. The reason for the discrepancy is
most likely multifactorial. There is little evidence to the benefit of AEDs in patients who have not
had seizures when considering the side effect profile of AEDs. However, give the litigious climate
of Philadelphia, many neurosurgeons are reluctant to leave a patient with an intracerebral lesion
without antiepileptic coverage. Additionally, many neurosurgeons are creatures of habit, trained
to practice a certain way, and have done so for many years during which “it has worked or them so
far.” A set of guidelines based on a literature search, where level I evidence is cited where possible,
would help physicians to be more comfortable about changing their practice.
http://commons.wikimedia.org/wiki/Image:Drug_
ampoule_JPN.jpg
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Since 2000, there have been practive guidelines
in place approved by the American Academy of
Neurology (see Ref 3) based on peer reviewed
publications with level I evidence. Despite these
practice parameters a recent survey reported
that 81% of neurosurgeons and 53% of neurologists prescribed antiepileptic drugs (AEDs)
prophylactically.
For the 20-40% of patients diagnosed with a
brain tumor who have experienced a seizure,
prophylactic use of AEDs is universally accepted.
Seventy percent of brain tumor patients
presenting with seizures will suffer recurrent
seizures regardless of tumor type. However,
patients that have not had a seizure still remain
at risk and 20-45% will develop seizures. Some
factors that have been shown to increase the
likelihood of developing seizures are:
1. Tumor location, most likely in frontal,
parietal or temporal lobes, especially
parasagital meningiomas (74% seizure
prevalence).
2. Number of tumors: increased number of
tumors correlates to higher seizure risk.
3. Tumor histopathology: Slow growing
tumors are at increased risk.
4. Age: younger patients more likely to seize.
One factor that is conspicuously absent from
the list above is AED use. Of the twelve studies
of Level I & II data that examined this question,
only one reported a significant difference in
seizure frequency and this favored the nonAED group having a lower seizure risk. A
meta-analysis performed on the four Level I
studies showed an Odds Ratio of 1.09 with no
statistical significance (p=0.9). Furthermore
AED use is not benign; 23.8% of these patients
experience side effects that warranted change
or discontinuation of the AED. These side
effects included rash (14%), nausea and
vomiting (5%), encephalopathy (5%), and
myelosuppression (3%).
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Cervical spondylotic myelopathy
Amgad Hanna, MD

We attempt to address the literature
controversies regarding this topic, the severity
of myelopathy, and the indications for surgery.

Online search for resources

http://commons.wikimedia.org/wiki/Image:The_
Thinker_wideshot.jpg

Cervical spondylotic myelopathy is a common
cause of major morbidity in middle-aged and
elderly people. Various functional classifications are used to evaluate patients with cervical
spondylosis. They are based on pure clinical
data, and are used as a method of evaluation of
the patient’s progress during the course of the
disease. None of these classifications defines
criteria for the indication for surgery.
Patients with cervical myelopathy may be
managed either conservatively or surgically.
Conservative management includes medications (e..g, non-steroidal anti-inflammatories
or corticosteroids), cervical orthotics, physical
therapy, or injections. Surgery includes anterior and/or posterior decompression and/or
fusion.
There remains considerable uncertainty
regarding the decision to operate and the
timing for surgery. This is left to the surgeon’s
discretion in most of the cases. Most surgeons
would agree that patients with mild myelopathy should be managed conservatively and
patients with severe myelopathy should be
managed surgically. There is a large gray zone
of moderate myelopathy where surgeons may
decide about surgery or conservative management. The definition of mild, moderate, or
severe myelopathy is vague in literature.
The timing of surgery is also controversial
in literature. Advocates of early surgery try
to stop disease progression, prevent further
clinical deterioration of the patients, and prevent the risk of acute deterioration with neck
injuries (central cord syndrome). Advocates
of late surgery try to delay the potential
complications of surgery like adjacent level
disease, spinal cord injury, cerebrospinal fluid
leak, infection, bleeding, and possible clinical
deterioration.

1. National guideline clearinghouse. We
searched for “cervical myelopathy”. No
guidelines were found for the management
of cervical myelopathy. Related guidelines
were found for cervical radiculopathy:
Review criteria for cervical surgery for
entrapment of a single nerve root. Olympia
(WA): Washington State Department of
Labor and Industries; 2004 June. 1p. The
article states that “Cases of myelopathy
should be referred for physician review”.
2. The Cochrane Library. We searched for “cervical myelopathy”. One article was found:
Cochrane review on the role of surgery in
cervical spondylotic radiculomyelopathy.
Fouyas I, Statham P, Sandercock P. Spine
2002; 27 (7): 736-47
3. Medline search: www.ncbi.nlm.nih.gov.
We searched for “management of cervical
myelopathy”; 104 articles were found

Summary of findings
There are no current guidelines for the management of cervical spondylotic myelopathy.
Several articles (1,2) discussed the prognostic
factors and presented surgical outcomes. These
articles presented conflicting results as far as
the prognostic significance of signal changes
on MRI, age, and duration of symptoms.
Other studies discussed the indications and
outcomes of different surgical approaches.
Again, conflicting results were found. Fouyas
et al. found no significant longterm differences
between surgery and conservative management3. Houten, Kim, Medow, Komotar, and
Sekhon showed good results with surgical
decompression 2, 4-7. However, there was no
comparison to conservative management.

Guidelines
The two articles selected are references 2 and 3.
Reference 2: Houten, Cooper (2003)
Full reference: Laminectomy and posterior cervical plating for multilevel cervical spondylotic
myelopathy and ossification of the posterior
longitudinal ligament: effects on cervical alignment, spinal cord compression, and neurological outcome. Houten J, Cooper P. Neurosurgery
2003; 52 (5): 1081-8
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Results

- Multilevel cervical laminectomy and
fusion for cervical spondylotic myelopathy provide minimal morbidity, excellent decompression, immediate stability,
prevent kyphosis, and precludes further
spondylosis.
Strengths

- Combined clinical and radiological criteria for outcome after surgery.

Final Guideline			
This guideline targets mainly neurosurgeons
and orthopedic spine surgeons who need to
decide for their patients whether to proceed
with surgical or conservative management. It
also targets primary care physicians to guide
them as to which patients need to be referred
for surgery.
Evaluation of the severity of myelopathy:

- Thirty months follow up.

The following scoring system is proposed to
evaluate the severity of cervical myelopathy:

Weaknesses

Comments

- Retrospective study.
- Small number of patients (38).
- No comparison group with conservative
management.
- No consideration for bony fusion vs
pseudoarthrosis.

Reference 3: Fouyas, Statham, Sandercock
(2002)
Full reference: Cochrane review on the role of
surgery in cervical spondylotic radiculomyelopathy. Fouyas I, Statham P, Sandercock P.
Spine 2002; 27 (7): 736-47

• This is the first grading system to include
both clinical and radiological data.
• Mild to moderate symptoms: mild pain or
numbness. Severe symptoms: severe pain
or numbness, loss of dexterity, difficulty in
walking.

2

No Signs

0

Mild to Moderate Signs

1

Severe Signs		

2

No stenosis

0

Moderate Stenosis

1

Severe Stenosis		

2

No signal changes
on MRI

0			

Signal Changes on MRI

2		

Total score 1-3: Conservative management. Total score 4-8: Surgery.

Results

clinical scenario, progression of the disease,
and co-morbidities.
References
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Surgical management of cervical myelopathy: indications
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Does the treatment of carotid
dissection require anticoagulation
with coumadin or is antiplatelet
therapy equally efficacious?
Aditya Pandey, MD

• This is just a guideline. Cases need to be
managed individually, based on the whole

Severe Symptoms		

- Patients represented in the studies had
mainly mild functional deficit. They do
not represent the population that usually
benefits from surgery, who have moderate to severe myelopathy.

Surgical management of cervical myelopathy: indications
and techniques for surgical corpectomy. Medow J, Trost G,
Sandin J. Spine J 2006; 6 Suppl: S 233-41

• The recommendations are based on the best
available literature.

1

Weaknesses

5.

• Moderate stenosis: Mid-sagittal diameter:
10-12 mm. Severe stenosis: Mid-sagittal
diameter: < 10 mm.

Mild to Moderate Symptoms

Strengths

Indications for circumferential surgery for cervical spondylotic myelopathy. Kim P, Alexander J. Spine J 2006; 6 Suppl:
S 299-307

• Mild to moderate signs: hyper-reflexia,
Hoffman’s or Babinski’s signs, mild weakness. Severe signs: significant weakness,
spasticity.

Table 1. Score System
No Symptoms
0

- No significant difference in long term outcome between surgical and conservative
management for cervical myelopathy.

4.

http://commons.wikimedia.org/wiki/Image:Blut-EDTA.jpg

Vessel dissection represents injury to the wall
of the vessel either from the luminal side or
adventitial (outside) side. Extracranial carotid
and vertebral artery dissections represent the
second leading cause of stroke in young adults.
Its incidence is 2-3 persons/ 100,000/ year.
The mechanism of developing stroke within
this patient population is from clot formation
at the site of the injury to the vessel. The
causes of carotid dissection are numerous, but
it most commonly occurs due to a traumatic
injury in an individual who has weakened
vessels. To prevent such an event, patients are
started on blood thinners: either antiplatelet
(aspirin) or coumadin.
Depending on physician and surgeon preference, different anticoagulation therapy can be
used for the same type of patient with carotid
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dissection. Those who use coumadin do so
since they have had success in treating carotid
dissection patients without stroke formation.
The same is true of physicians utilizing antiplatelet therapy. The use of coumadin not only
requires that patients have frequent blood tests
to show level of blood thinning but also that the
bleeding risks associated with it are higher. The
goal of this analysis is to present the evidence
for using coumadin versus aspirin in the treatment of carotid dissection.

Benefits of Full Anticoagulation
• anticoagulation leads to the prevention of
stroke from the formation of clots at the site
of the vessel injury

Complications of Full Anticoagulation
• anticoagulation could lead to further bleeding into the brain

Specifics of Search
• Search of National
Clearinghouse
Guidelines revealed one review but no
specific guidelines
• Search of the Cochrane Database did not
reveal any position statements on the
subject
• The following key term searches on Pubmed led to numerous articles on the subject
of treating carotid dissection with anticoagulation:
- “Extracranial carotid dissection”
- “Treatment of extracranial carotid dissection”
- “Anticoagulation for extracranial carotid
dissection”
Results
1. Antithrombotic drugs for carotid artery dissection. Cochrane Database Syst Rev. 2000;
(4): CD 000255
Strengths

- comprehensive review of case controlled
studies and case series
- applies to carotid dissection patients who
had undergone either anticoagulation
with coumadin or antiplatelet therapy
Limitations

- No statistically significant difference in
outcome (mortality/disability) between
patients on antiplatelet therapy versus
those on anticoagulation (coumadin)
- No difference in the occurrence of intracerebral hemorrhage between the two
groups (0% for antiplatelet group and
0.5% for anticoagulation group)

Conclusion
- no statistically significant difference in
outcome or complication when comparing the anticoagulation versus the
antiplatelet group of patients
2. Cervical Arterial Dissection: time for a
therapeutic trial? Stroke. 2003 Dec; 34 (12):
2856 – 60
Strengths

- prospective enrolled patients with carotid
and vertebral dissections
- large number of patients (n=116)
- comparison of aspirin vs. anticoagulation
Weaknesses

- not a randomized control trial
- N might not be large enough to a small
statistically significant difference
Summary

- Canadian Stroke Consortium prospectively enrolled patients with extra-cranial
dissections and followed patients for
one year. The endpoints being evaluated included: TIA, Stroke, or Death.
105 patients had complete follow up. In
patients treated with anticoagulation the
event rate was 8.3% versus those treated
with aspirin where the event rate was
12.4%. While there was an absolute difference of 4.1%, this difference was not
statistically significant.

Conclusion
There were no statistically significant differences between the outcome rates of patients on
ASA versus those on anticoagulation.
1. Dissection of Cervical Arteries: Long-term
follow-up study of 130 consecutive cases.
Cerebrovasc Dis. 2006; 22 (2-3): 150-4

- no randomized control trials included in
this study (No RCT have been performed
addressing this issue)

Strengths

Summary

- Comparison of ASA vs. anticoagulation

- 26 eligible studies were reviewed (327
patients)

- Prospective Study
- N=130 cases

Summary

- 130 patients with angiographically
proven cervical arterial dissection were
followed for the events of stroke and
death. There was no significant differences in outcome were found when
comparing patients on aspirin versus
the patients on anticoagulation.

Conclusion
In patients with proven carotid dissections,
there is no difference in outcome between
patients treated with ASA vs. those treated with
anticoagulation.
1. Outcome of extracranial cervicocephalic
arterial dissections: A follow-up study.
Neurol Res. 2002 Jun; 24 (4): 395-8
Strengths

- comparison of ASA vs. anticoagulation
- long term f/u (nearly 10 years)
Weaknesses

- not a randomized control trial
- small patient population (n=27)
Summary

- 27 patients with extracrainal CAD who
were treated and followed by the stroke
service. Outcome was assessed using the
modified Rankin Score and recurrent
stroke and TIAs were also recorded. The
outcome was favorable with either antiplatelet or anticoagulation.

Conclusion
Either antiplatelets or anticoagulation are
equally effective in preventing strokes after
carotid dissection,
Final Guideline
In individuals with a proven extracranial
carotid dissection, aspirin therapy should be
initiated instead of coumadin. The current
literature on the subject shows no statistically
significant difference in outcome of individuals
treated with aspirin versus those treated with
coumadin in the setting of carotid dissection.
While the risks with coumadin are not higher,
it still requires evaluation of the INR for accurate dosing. Such is not the requirement of
antiplatelet therapy. In addition other medications (cimetidine) can affect the metabolism of
coumadin thus leading to inappropriate levels
of anticoagulation. Thus antiplatelet therapy is
an effective method of preventing strokes in
individuals with carotid dissection.

Weaknesses

- not a randomized control trial
- F/U only 6 months

https://jdc.jefferson.edu/jhnj/vol4/iss2/7
DOI: https://doi.org/10.29046/JHNJ.004.2.003
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Would a standardized protocol for the
inter-hospital transport of critically ill
patients alter outcomes?
Jack Klem, MD

The rapid evolution of healthcare technology
has created a disparity among hospitals and
thus led to the establishment of highly specialized quarternary institutions, termed “Centers
of Excellence.” This has created a need for the
systematic triage and transport of certain critically ill patients that would not receive adequate
care at a community hospital. Emergency
Medical Services (EMS) has made the transport
of patients a national issue due to regionalization, specialization, and facility designation
by payers. Despite this, there exists a paucity
of guidelines to direct the appropriate flow of
patients to higher levels of care.
Diversity exists amongst transport teams
and overall resource allocation. Interfacility
transport is provided by a variety of levels and
types of personnel and agencies. The medical
condition of the patient is not always matched
appropriately with the acuity of care provided
by the transport team. Less severely ill patients
are sometimes intubated and ventilated solely
to facilitate ease and safety of transport.
In addition, the disease process of a particular
diagnosis is not always understood prior to
dispatching the appropriate means of transport
(ie, air vs. ground). For example, patients
with suspected aneurysmal subarachnoid
hemorrhage require the most expeditious
mode of transportation due the high risk of rerupture in the acute period. Moreover, certain
diagnoses such as cerebellar hematoma with
deteriorating neurological function require
immediate transfer to the operating room with
no need for an available ICU bed. Recognition
of these “hyperacute” scenarios are critical to
patient outcome.
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Guidelines are necessary to standardize interfacility transport on at least the regional level.
Several steps must be analyzed in order to
establish a systems-based protocol for interfacility transfer. The type of transfer must be
established (ie, hospital to hospital, rehab to
hospital, clinic to hospital, etc.) Next, provider
capabilities must match the patient’s current
and potential needs in order to provide safe and
effective care during transport. This has been
shown to impact outcomes in the transport of
pediatric patients. On an administrative level,
certification of necessity for transfer is a requirement for reimbursement by Medicare and
Medicaid. This is directed by federal legislation
outlined in the Consolidated Omnibus Budget
Reconciliation Act (COBRA) and Emergency
Medical Treatment and Labor Act (EMTALA).
In summary, all of these factors must be integrated in order to develop a regional or even
national plan for interfacility transport. This
shall streamline resource allocation and potentially improve outcomes

Online Search
1. National Guidelines Clearinghouse was
queried for “patient, hospital transport” and
“interhospital transport”
2. Google was queried for “patient transport,
guidelines” and “hospital transport”
Study #1: Warren at al (2004)
Full reference: Warren et al. Guidelines for
the inter- and intrahospital transport of critically ill patients. Crit Care Med 32:1 (2004)
256- 262.
Purpose

- Development of practice guidelines for
inter- and intrahospital transport of the
critically ill patient in order to establish
an efficient, organized process supported
by appropriate equipment and personnel.
This would ultimately enhance patient
safety.
Methods

- Synthesis of prospective clinical outcome
studies, retrospective reviews, and anecdotal reports by a task force of experts
providing consensus opinion.
Results

- A multidisciplinary team of physicians,
nurses, respiratory therapists, hospital
administration and the local emergency
medical service must justify and coordinate the process by conducting a needs
assessment of the referring hospital or
clinic, asking whether transport is likely

to alter the management or outcome of
the patient. A patient must have a preliminary diagnosis that can be further
refined and ultimately treated at a center
that offers specialized diagnostic capability. Receiving hospitals should then proceed with a formalized plan addressing
the following points:
- pretransport coordination and communication
- transport personnel
- transport equipment:
- monitoring during transport
- documentation: The patient’s medical record and relevant laboratory and
radiographic studies must be copied for
the accepting facility. It is also suggested
to perform a COBRA/EMTALA checklist to ensure compliance with federal
regulations.
- The above five points should be evaluated and refined regularly by the hospital
using a standard quality improvement
process. Many of the specific details from
these guidelines are incorporated in the
final guidelines below.

Conclusions
When services are required that exceed available resources at a particular hospital or clinic,
a patient will be ideally transferred to a facility
that has the necessary resources. The decision
to transport a critically ill patient is based on
the potential benefits (ie, higher level of technical/cognitive/procedural care) and weighed
against the risks. Justification for transport
must be established and several points must
be addressed to ensure safe and efficient
transfer.
Strengths of study

- Article provides clear, comprehensive
guidelines discussed above for transporting patient within and between hospitals.
Not only do these guidelines comply with
federal regulations, but they also illustrate
the importance of having an organized,
efficient and standardized protocol that
can be followed by any hospital.
- Details of transport such as appropriate
equipment and personnel are described
in order to ensure utmost safety for the
patient being transported. Again, this is
an effort to standardize the entire process
in order to eliminate “system-based”
mistakes. For example, there exists much
variability in the acuity of care provided
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by transport teams due to improper
triage, insufficient equipment, and
inexperienced personnel. To resolve this,
this article takes the stance that patient
transportation must be subjected to the
same rigors as the aviation industry in
eliminating systems errors by establishing
a universal set of guidelines.
Weaknesses of study

Conclusion

Conclusions

Insufficient data exists regarding the mortality,
morbidity, and risk factors associated with the
interfacility transport of critically ill patients.
Further research is necessary to understand
which patients are most at risk while being
transported. Recognizing the types of events
that can occur is an important step in patient
preparation and planning.

Important factors for improvement were better
overall communication between the referring/ receiving hospital and strict adherence to
checklists/ published protocols.

- This is really the first effort in the literature
to establish a universal set of guidelines
and, as a result, no outcome studies are
yet available.

Strengths of study

- This article also assumes that every hospital has the same basic resources available
to standardize patient transport. This
becomes an issue with the transport of
critically ill patients where the accepting
hospital may have to provide the appropriately staffed and equipped transportation team.

Weaknesses of study

Study #2: Fan et al (2006)
Full reference: Fan et al. Outcomes of interfacility critical care adult patient transport: a
systematic review. Critical Care 10 (2006) 1-7.
Purpose

- Determine the adverse events and important prognostic factors associated with
interfacility transport of intubated and
mechanically ventilated adult patients.
Methods

- A systematic review of multiple databases
yielded 5 case-series comprising of a total
of 245 patients. Two of the case-series
were prospective in design.
Results

- Data was synthesized in a qualitative
manner due to significant heterogeneity
in study population, outcome events, and
results. The most common indication for
interfacility transport was a need for specialized investigations and interventions.
Transport modalities included air (66%),
ground (31%) and commercial aircraft
(3%). Transport teams included a physician in 3 of the 5 studies. Death during
transport was rare (n=1) and no other
adverse events or significant therapeutic
interventions were reported during
transport. Of note, one study reported
a 19% (28/145) incidence of respiratory
alkalosis upon arrival.
-

https://jdc.jefferson.edu/jhnj/vol4/iss2/7
DOI: https://doi.org/10.29046/JHNJ.004.2.003

- First attempt to study outcomes of interhospital transport of critically ill patients

- This is similar to a meta-analysis that
combines different levels of evidence
(ie, three retrospective studies plus two
prospective studies) and attempts to draw
meaningful conclusions. There must be
one prospective trial that addresses the
same patient population.
- This article looks only at adverse outcomes that occur while a patient is en
route rather than considering the period
just before and after transport. This under
reports situations, for example, where
some patients begin to deteriorate and
are intubated immediately upon arrival.
Study #3: Ligtenberg et al (2005)
Full reference: Ligtenberg et al. Quality of
interhospital transport of critically ill patients:
a prospective audit. Critical Care 9 (2005)
446-51.
Purpose

- Determine the adverse events and important prognostic factors associated with
interfacility transport.
Methods

- prospective study describing 100 consecutive ICU transfers, of which 65%
were mechanically ventilated and 38%
on vasoactive drugs.
Results

- Data was collected on adverse events
before, during, and after transport. 34%
of patients incurred adverse events with
6 deaths being reported within the first
24-hours after arrival. This study was
different because not all patients were
intubated and not all were accompanied
by a physician as was the case in Fan et
al. (2006).

Strengths of study

- Describes a single, prospective study
involving the transfer of 100 patients into
only one university center. This eliminates the inherent flaws of a combining
several different studies.
- Information regarding adverse events
was collected for 24-hours after arrival.
Weaknesses of study

- There was no stratification of diagnoses.
For example, there is no discussion as
to why each of the 34 adverse events
occurred. For example, was this due to
inadequate stabilization of the patient’s
medical condition prior to transport,
due to inadequate care provided during
transport, or merely patient disease?
Final Guidlines for inter-hospital transport of
critically ill patients
Diagnosis

- Patient requires emergent surgical intervention that will occur immediately upon
arrival to the accepting institution. This
applies to diagnoses such as cerebellar
hematoma, EDH, or SDH in the setting
of a rapidly deteriorating patient. This
defines the highest acuity transfer wherein
communication between physicians, OR
staff, and transport personnel is critical to
transporting a patient directly to the holding area and/or operating room in order
to save the patient’s life. Expending time
to “make a bed” at the accepting institution will gravely impact the patient’s
outcome and thus must be overlooked in
order to transport the patient as rapidly as
possible to the operating suite.
- Patient requires emergent surgical
intervention within 24-hours of arriving
to the accepting institution. This applies
to diagnoses such as SAH where cerebral
angiogram with definitive treatment is
performed within 24-hours of arrival.
The caveat here is that these patients may
develop hydrocephalus which sometimes
cannot be treated at a referring institution
and therefore requires emergent transport. Another diagnosis is cauda equina
where a patient will require an MRI followed by surgery within 24-hours.
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- Patient requires urgent imaging studies that may or may not require surgery
in the setting of a neurologically and
medically stable patient. This applies to
diagnoses such as cervical spine trauma
where the patient’s neurological status
is not changing. For example, a patient
with facet dislocation requiring traction
and/or reduction.
- Patient requires observation in a
neurosurgical ICU, but remains stable
neurologically. This applies to diagnoses
such as a basal ganglia hemorrhage.
- Patient does not have an established
diagnosis due to lack of MRI, angiography, etc. at the referring institution but
remains neurologically stable.
PRE-TRANSPORT COORDINATION
Communication is Key

- Establish continuity of care by physician-to-physician and nurse-to-nurse
review of patient condition and current
treatment plan. Receiving physician
should provide advice to aid in pretransport stabilization and provide advance
medical treatment when appropriate (ie,
Mannitol, steroids, antiepileptic in setting
of aneurysmal SAH with hydrocephalus).
The appropriate arrangements should
be made at the receiving institution to
avoid delays in definitive treatment (ie,
operating room standby). The mode
of transport must also be established.
Communication is especially critical in
the setting of the first set of diagnoses
described above.
TRANSPORT PERSONNEL
Education = Empowerment to Intervene

- A minimum of two people should accompany a critically ill patient consisting of a
critical care nurse plus a technician. In the
case of an unstable patient, it is recom-
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mended that a physician with training in
airway management and ACLS be present. When this is not possible, some
hospitals prophylactically intubate those
patients who have a high risk for becoming unstable en route. In the setting of
elevated ICP, the transport personnel
must understand the diagnosis and
means of controlling ICP during transport. For example, most patients arrive
flat and supine which is not the optimal
position for a patient with impending
hydrocephalus. Transport personnel
cannot serve as technicians, but must be
aware of the patients diagnosis in order
to best maintain and even optimize the
patient prior to arrival.

The above five points serve as a general set of guidelines that should be
evaluated and refined regularly by
the hospital using a standard quality
improvement process. The hospital
transfer center should develop a checklist for each of the five points described
above and follow the same steps for each
and every transfer. Attention to details
by methodically following the same
steps in each situation will hopefully
minimize “systems” mistakes and thus
not only improve efficiency, but also
maximize safety.

TRANSPORT EQUIPMENT
Continuity of Care

- The patient must be maintained using the
same monitors and drugs (if necessary)
as are present in the ICU. A blood pressure monitor, pulse oximeter, cardiac
monitor/ defibrillator, basic rescucitation
drugs, and a portable mechanical ventilator when indicated.
DOCUMENTATION:
What is the Goal of Transfer?

- The patient’s medical record and
relevant laboratory and radiographic
studies must be copied for the accepting
facility. It is also suggested to perform a
COBRA/EMTALA checklist to ensure
compliance with federal regulations. This
includes documentation of initial medical
evaluation and stabilization procedures,
informed consent disclosing risks and
benefits of transfer, and documentation
of physician-to-physician communication with the names of each physician
involved. Financially motivated transfers
are illegal.
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